For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Facet Biotech Corporation

USPTO Granted Patents = 17

% Expired Patents = 41.2

EPO Patents = 4

Forward Citations = 123

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Vinay Bhaskar (8 out of 39 patents)

Vanitha Ramakrishnan (6 out of 20 patents)

David Powers (6 out of 29 patents)

4. Debbie Law (6 out of 10 patents)

5. Naoya Tsurushita (4 out of 50 patents)

6. Daniel E Afar (4 out of 36 patents)

7. Richard Murray (4 out of 6 patents)

8. Agustin De La Calle (3 out of 5 patents)

9. Paul Robert Hinton (3 out of 21 patents)

10. Ingrid W Caras (3 out of 16 patents)

11. Robert B Dubridge (2 out of 49 patents)

12. Paul J Maddon (2 out of 48 patents)

13. Supriya Gupta (2 out of 15 patents)

14. William C Olson (2 out of 88 patents)

15. Elizabet Kaisheva (2 out of 4 patents)

17 patents: Sort by Forward Citations

1. 8298530 - Stable lyophilized pharmaceutical formulation of IgG antibodies (2012-10-30),

2. 7914789 - HEMCM42 antibodies (2011-03-29),

3. 7879987 - Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis (2011-02-01),

4. 7851600 - Anti-CCR5 antibody (2010-12-14),

5. 7842293 - Compositions and methods using anti-CS1 antibodies to treat multiple myeloma (2010-11-30),

6. 7824678 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-11-02),

7. 7807163 - Antibodies against GPR64 and uses thereof (2010-10-05),

8. 7785816 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-08-31),

9. 7776585 - Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis (2010-08-17),

10. 7732570 - Alteration of Fc-fusion protein serum half-lives by mutagenesis (2010-06-08),

11. 7732195 - Tethered vectors for cell surface immunoglobulin display (2010-06-08),

12. 7709610 - Therapeutic use of anti-CS1 antibodies (2010-05-04),

13. 7674883 - Antibodies against cancer antigen TMEFF2 and uses thereof (2010-03-09),

14. 7666419 - Anti-CCR5 antibody (2010-02-23),

15. 7662384 - Use of anti-α5β1 antibodies to inhibit cancer cell proliferation (2010-02-16),

Facet Biotech Corporation is a biotechnology company specializing in the discovery, development, and commercialization of novel therapeutics. With a strong focus on oncology and immunology, Facet Biotech aims to deliver groundbreaking treatments to improve patient outcomes. Through strategic collaborations and innovative research, the company strives to revolutionize the field of biotechnology and bring hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

17 Patents

#103 in Redwood City, CA

#4,503 in California

#18,850 in US

#35,824 in the World

Redwood City, CA, United States of America

Facet Biotech Corporation

Forward Citations = 123

31 inventors:

Vinay Bhaskar (8 out of 39 patents)

Vanitha Ramakrishnan (6 out of 20 patents)

David Powers (6 out of 29 patents)

4. Debbie Law (6 out of 10 patents)

5. Naoya Tsurushita (4 out of 50 patents)

Please report any incorrect information to [email protected]

Loading…